Sudden Cardiac Death: A Handbook for Clinical Prac tice
A Handbook for Clinical Practice
Samenvatting
This book draws on the established European guidelines from the ESC that address the key issues in sudden cardiac death, such as identifying individuals at risk prior to an episode of a ventricular tachyarrhythmia or a sudden cardiac arrest, and responding in a timely fashion to the person suffering the event out–of–the–hospital. It presents an update on what is known about sudden cardiac arrest, from basic experimental studies to clinical trials, and serves as a complement to the ESC Core Syllabus on this subject.
Topics include epidemiology, genetics, arrhythmogenic mechanisms, risk stratification, autonomic nervous system and phenotypes. Disease states and special populations are also covered, as well as drug, device and ablation treatments, and cost effectiveness. All chapters are co–authored by experts from both Europe and the US.
The ESC Education Series
This book is part of the ESC Education Series. The series is designed to provide medical professionals with the latest information about the understanding, diagnosis and management of cardiovascular diseases. Where available, management recommendations are based on the established European Guidelines, which encompass the best techniques to use with each cardiac disease. Throughout the series, the leading international opinion leaders have been chosen to edit and contribute to the books. The information is presented in a succinct and accessible format with a clinical focus.
Specificaties
Inhoudsopgave
<p>1 Epidemiology of cardiac arrest.</p>
<p>Robert J. Myerburg and Hein J.J. Wellens.</p>
<p>2 Geneticpredisposition and pathology of sudden cardiacdeath.</p>
<p>Xavier Jouven, Allen P. Burke, and Renu Virmani.</p>
<p>3 Arrhythmogenic mechanisms.</p>
<p>Michiel J. Janse and Douglas P. Zipes.</p>
<p>4 Risk stratification for SCD.</p>
<p>Stefan H. Hohnloser and Wojciech Zareba.</p>
<p>5 Autonomic nervous system: Emerging concepts and clinical.</p>
<p>applications.</p>
<p>Peter J. Schwartz and Richard L. Verrier.</p>
<p>6 Clinical characteristics of sudden cardiac death victims and.</p>
<p>precipitating events.</p>
<p>Christine M. Albert and Stuart M. Cobbe.</p>
<p>SECTION 2 DISEASE STATES AND SPECIAL POPULATIONS.</p>
<p>7 Ischemic heart disease.</p>
<p>William Wijns and Elliott M. Antman.</p>
<p>8 The cardiomyopathies.</p>
<p>William J. McKenna, Srijita Sen–Chowdhry, and Barry J. Maron.</p>
<p>9 Inherited arrhythmogenicdiseases.</p>
<p>Silvia G. Priori and Charles Antzelevitch.</p>
<p>10 Sudden cardiac death and valvular heart diseases.</p>
<p>David Messika–Zeitoun, Bernard J. Gersh, Olivier Fondard, and Alec Vahanian.</p>
<p>11 Heart failure.</p>
<p>William G. Stevenson and Helmut Drexler.</p>
<p>12 Drug–induced sudden death.</p>
<p>Dan M. Roden and Milou–Daniel Drici.</p>
<p>13 Sudden death in athletes.</p>
<p>Domenico Corrado, Cristina Basso, Mark S. Link, Gaetano Thiene, and.</p>
<p>N.A. Mark Estes III.</p>
<p>SECTION 3 TREATMENT.</p>
<p>14 Pharmacology of sudden cardiac death.</p>
<p>Timothy W. Smith, Michael E. Cain, Günter Breithardt, and.</p>
<p>Paulus Kirchhof.</p>
<p>15 Implantable devices.</p>
<p>A. John Camm and Arthur J. Moss.</p>
<p>16 Sudden cardiac death: ablation.</p>
<p>Prashanthan Sanders, John M. Miller, Mélèze Hocini,.</p>
<p>Pierre Jaïs, and Michel Haïssaguerre.</p>
<p>17 External automated defibrillators.</p>
<p>M.A. Peberdy, K.A. Ellenbogen, and D.A. Chamberlain.</p>
<p>18 Cost–effectiveness of implantable cardioverter–defibrillators.</p>
<p>Giuseppe Boriani and Greg Larsen.</p>
<p>Index</p>
